Gf Fund Management Co. Ltd.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-29
Total Holdings
666
Total Value
4262829836
Accession Number
0002057060-25-000003
Form Type
13F-HR
Manager Name
Gf Fund Management Co. Ltd.
Data Enrichment
99% identified
658 identified8 unidentified

Holdings

666 positions
Manager:
Search and click to pin securities to the top
Page 30 of 34
GALAPAGOS NV
Shares:
357(+21.8%)
Value:
$9.0M(+11.3%)
Entrada Therapeutics, Inc.
Shares:
958(+22.0%)
Value:
$8.7M(-36.2%)
Cartesian Therapeutics, Inc.
Shares:
650(+21.7%)
Value:
$8.6M(-10.4%)
ONE LIBERTY PROPERTIES INC
Shares:
321(+4.2%)
Value:
$8.4M(+0.5%)
RIGEL PHARMACEUTICALS INC
Shares:
451(+21.9%)
Value:
$8.1M(+30.4%)
MARAVAI LIFESCIENCES HOLDINGS, INC.
Shares:
3631(+21.9%)
Value:
$8.0M(-50.5%)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Shares:
6791(+18.1%)
Value:
$8.0M(-23.9%)
Autolus Therapeutics plc
Shares:
5113(+21.9%)
Value:
$7.9M(-19.6%)
Allogene Therapeutics, Inc.
Shares:
5368(+21.9%)
Value:
$7.8M(-16.4%)
Astria Therapeutics, Inc.
Shares:
1444(+21.9%)
Value:
$7.7M(-27.2%)
DIVERSIFIED HEALTHCARE TRUST
Shares:
3159(+4.0%)
Value:
$7.6M(+8.6%)
Hudson Pacific Properties, Inc.
Shares:
2541(+10.9%)
Value:
$7.5M(+7.9%)
Aura Biosciences, Inc.
Shares:
1279(+21.9%)
Value:
$7.5M(-13.1%)
OmniAb, Inc.
Shares:
3099(+21.9%)
Value:
$7.4M(-17.3%)
Absci Corp
Shares:
2941(+21.9%)
Value:
$7.4M(+16.8%)
MAXCYTE, INC.
Shares:
2701(+21.9%)
Value:
$7.4M(-20.0%)
Arcturus Therapeutics Holdings Inc.
Shares:
693(+21.8%)
Value:
$7.3M(-24.0%)
Taysha Gene Therapies, Inc.
Shares:
5248(+22.0%)
Value:
$7.3M(-2.0%)
Monte Rosa Therapeutics, Inc.
Shares:
1572(+21.9%)
Value:
$7.3M(-18.5%)
Esperion Therapeutics, Inc.
Shares:
5045(+21.9%)
Value:
$7.3M(-20.2%)